SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-23-093931
Filing Date
2023-08-21
Accepted
2023-08-21 16:16:40
Documents
1
Group Members
COSTAS CONSTANTINIDESIAN CHAROUBNEXTECH CROSSOVER I SCSPROCCO SGOBBO

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2324134d1_sc13g.htm SC 13G 117267
  Complete submission text file 0001104659-23-093931.txt   118984
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Subject) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92241 | Film No.: 231189304
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 RUE LOU HEMMER SENNINGERBERG N4 L-1748
Business Address 8 RUE LOU HEMMER SENNINGERBERG N4 L-1748 41.443666611
Nextech Crossover I GP S.a r.l. (Filed by) CIK: 0001916761 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G